Profound Medical Corp. (PROF)
NASDAQ: PROF · Real-Time Price · USD
6.73
-0.16 (-2.32%)
At close: May 19, 2026, 4:00 PM EDT
6.76
+0.03 (0.45%)
After-hours: May 19, 2026, 4:04 PM EDT
Profound Medical Revenue
Profound Medical had revenue of $5.34M in the quarter ending March 31, 2026, with 103.62% growth. This brings the company's revenue in the last twelve months to $18.81M, up 65.17% year-over-year. In the year 2025, Profound Medical had annual revenue of $16.10M with 50.73% growth.
Revenue (ttm)
$18.81M
Revenue Growth
+65.17%
P/S Ratio
12.97
Revenue / Employee
$116,136
Employees
162
Market Cap
243.95M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.10M | 5.42M | 50.73% |
| Dec 31, 2024 | 10.68M | 3.48M | 48.35% |
| Dec 31, 2023 | 7.20M | 518.00K | 7.75% |
| Dec 31, 2022 | 6.68M | -192.00K | -2.79% |
| Dec 31, 2021 | 6.87M | -431.00K | -5.90% |
| Dec 31, 2020 | 7.30M | 3.13M | 74.99% |
| Dec 31, 2019 | 4.17M | 2.26M | 117.58% |
| Dec 31, 2018 | 1.92M | -1.98M | -50.81% |
| Dec 31, 2017 | 3.90M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pacific Biosciences of California | 160.03M |
| InfuSystem Holdings | 142.40M |
| RxSight | 127.48M |
| Sight Sciences | 79.55M |
| Electromed | 71.75M |
| 908 Devices | 57.80M |
| Senseonics Holdings | 40.71M |
| ClearPoint Neuro | 40.61M |
PROF News
- 4 days ago - Telix announces LoI to collaborate with EDAP TMS and Profound Medical - TheFly
- 5 days ago - Profound to Showcase TULSA-PRO®, the TULSA Procedure™ and the Future of iMRI at AUA2026 - GlobeNewsWire
- 6 days ago - Profound Medical Annual General and Special Meeting of Shareholders Voting Results - Newsfile Corp
- 6 days ago - Profound Medical Corp Annual Shareholders Meeting Transcript - GuruFocus
- 7 days ago - Profound Medical files to sell 921,428 common shares for holders - TheFly
- 7 days ago - Profound Medical Registration statement: Registration filing - Filings
- 11 days ago - Profound Medical price target lowered to $10 from $12 at Stifel - TheFly
- 11 days ago - Q1 2026 Profound Medical Corp Earnings Call Transcript - GuruFocus